Hepatitis C virus (HCV), one of the major causative agents of virus-related liver cirrhosis and hepatocellular carcinoma in humans, contains a single-stranded RNA genome of positive polarity. HCV RNA contains nontranslated regions (NTRs) at the 5Ј and 3Ј ends (18, 23) and a long open reading frame encoding polyprotein that is synthesized through a single translational initiation event directed by an RNA element designated the internal ribosomal entry site (IRES) (21, 38) at the 5Ј NTR (46). The polyprotein is proteolytically processed into 10 or more viral proteins.
Hepatitis C virus (HCV), one of the major causative agents of virus-related liver cirrhosis and hepatocellular carcinoma in humans, contains a single-stranded RNA genome of positive polarity. HCV RNA contains nontranslated regions (NTRs) at the 5Ј and 3Ј ends (18, 23) and a long open reading frame encoding polyprotein that is synthesized through a single translational initiation event directed by an RNA element designated the internal ribosomal entry site (IRES) (21, 38) at the 5Ј NTR (46) . The polyprotein is proteolytically processed into 10 or more viral proteins.
In general, IRES elements need several canonical translation factors (except eukaryotic initiation factor 4E [eIF4E]) for their activities (40, 42) . However, HCV IRES-dependent translation requires only a few canonical factors (eIF2, eIF3, eIF5, and eIF5B) for function (30, 39, 41) . Additionally, cellular proteins known as IRES-specific cellular transacting factors (ITAFs) are required for the efficient translation of HCV mRNA. For instance, polypyrimidine tract-binding protein (PTB) interacting with HCV IRES is required for IRES function (2, 3) . La antigen interacting with the GCAC site near the initiator AUG is necessary for the optimal function of the HCV IRES (1, 10, 43) . Recent studies have shown that NSAP1 interacting with the adenosine-rich core-coding region of HCV mRNA augments HCV IRES-dependent translation (27) .
Heterogeneous ribonucleoprotein D (hnRNP D), also known as AU-rich element RNA-binding protein 1 (AUF1), is an hnRNP family member that shuttles between the nucleus and cytoplasm (44, 48) . hnRNP D was initially identified owing to its ability to bind and destabilize c-myc mRNA in a crude in vitro decay system (6) . The protein has four isoforms of different molecular weights (p37, p40, p42, and p45), all of which are produced by alternate splicing of a single transcript (11, 47) . The hnRNP D protein has various functions, including mRNA decay (6) , telomere maintenance (12) , translation initiation (31, 36) , and mCRD-mediated mRNA turnover (16) . Another recent report showed that hnRNP D enhances the translation of c-myc mRNA (33) .
Here CAT. PCR fragments were treated with Asp718-BamHI and cloned into the corresponding sites of pH CAT.
To construct a plasmid expressing short hairpin RNA (shRNA) against hnRNP D, we selected the target site on hnRNP D mRNA corresponding to nucleotides (nt) 867 to 895 (exon 7) downstream of the initiation codon. The DNA oligomers 5Ј-CTAGTCGACCTGGAACCAGGGATATAGTAACTATT GGATTCAAGAGATCCAATAGTTACTATATCCCTGGTTCCAGTTTTTC TAGAGA-3Ј and 5Ј-CTAGTCGACCTGGAACCAGGGATATAGTAACTAT TGGACTTCCTGTCATCCAATAGTTACTATATCCCTGGTTCCAGTTTTT CTAGAGA-3Ј were annealed and ligated into plasmid pEBV-U6ϩ27 (8) treated with SalI and XbaI.
Duplex siRNAs targeting exon 1 of hnRNP D (nt 201 to 219) and control siRNA were purchased from Bioneer Inc. (Korea). The siRNA sequence targeting hnRNP D and the control RNA sequence were 5Ј-GAUUGACGCCAG UAAGAAC(dTdT)-3Ј and 5Ј-CCUACGCCACCAAUUUCGU(dTdT)-3Ј, respectively.
Cell culture. 293T, Huh7, and Huh 7.5.1 cells were cultured in Dulbecco's modified Eagle's medium (Gibco) supplemented with 10% fetal bovine serum (Clontech). FK cells containing the full-length HCV genome (32) and Huh-luc/ neo-ET cells containing the subgenomic replicon carrying both the neomycin phosphotransferase and firefly luciferase genes (25) were grown in Dulbecco's modified Eagle's medium (Gibco) supplemented with 10% fetal bovine serum (Clontech) and the antibiotic G418 (600 g/ml; Calbiochem). Huh 5-15 cells containing the subgenomic replicon I 389 hyg-ubi/NS3-3Ј were provided by R. Bartenschlager at the University of Heidelberg (13) . Cells were grown in Dulbecco's modified Eagle's medium (Gibco) with 10% fetal bovine serum (Clontech) and hygromycin (300 g/ml; Calbiochem).
Antibodies. Anti-Flag and anti-NSAP1 antibodies were purchased from Sigma, anti-actin antibody from ICN, and anti-hnRNP D antibody from Upstate Biotechnology. Anti-PTB and anti-La (7), anti-NS5B and anti-core (32) , and anti-NS5A (24) antibodies have been described elsewhere.
UV cross-linking and immunoprecipitation of cross-linked proteins. All experiments were performed according to previous reports (26) , except that 32 P-labeled RNA corresponding to fragments of HCV IRES and purified hnRNP D were used as the interacting RNA and protein, respectively.
RNA affinity chromatography. RNA affinity chromatography experiments were performed as described previously (27) , except that Huh7 cytoplasmic extracts and biotinylated RNA corresponding to HCV IRES fragments were used.
Establishment of cell clones expressing hnRNP D shRNAs. HeLa cells were transfected with control plasmids or those expressing shRNA (pEBV-U6ϩ27 and pEBV-U6ϩ27/hnRNP D; 1 g each) by electroporation. From 48 h posttransfection, cells were maintained in Dulbecco's modified Eagle's medium containing hygromycin (300 g/ml; Calbiochem). After 1 month of selection, hygromycin-resistant colonies were pooled and cultivated for further analysis.
Preparation of HeLa S10 cell extracts and in vitro translation. Cytoplasmic S10 extracts of HeLa S3 cells were prepared as specified in an earlier report (9) . In vitro translation reactions in HeLa S10 were performed for 1 h in a 12.5-l reaction mixture (130 mM potassium acetate and 1.5 mM magnesium acetate) containing 10 nM mRNA at 30°C.
RNA purification and analysis. Total RNA was extracted using the TRI reagent (Invitrogen). Total RNA (20 g) from transfected 293T cells was analyzed by Northern blot analysis (8) . Total RNA (2 g) was reverse transcribed using Improm II reverse transcriptase (Promega), and the cDNA was subjected to real-time PCR analysis for quantification using Sybr premix Ex Taq (Takara). Primer sequences for reverse transcription-PCR and real-time PCR were as follows: HCV, 5Ј-GTCTAGCCATGGCGTTAGTA-3Ј and 5Ј-CTCCCGGGGC ACTCGCAAGC-3Ј (29); glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 5Ј-TGCACCACCAACTGCTTAG-3Ј and 5Ј-GAGGCAGGGATGATGTTC-3Ј (45) .
Ribosomal profiling. Huh 5-15 cells were subjected to sucrose gradient analysis, as described elsewhere (8) . Fractionated samples were classified as shown below in Fig. 6 . Total RNA of each fraction was purified using TRI reagent (Invitrogen) and subjected to real-time PCR analysis for quantification.
Virus infection. Preparation of infectious JFH 5A-RLuc and infection experiments were performed as described in a previous report (24) .
RESULTS

hnRNP D enhances HCV IRES-dependent translation.
Since hnRNP D is cofractionated and coimmunoprecipitated with NSAP1 (16) , which enhances HCV IRES activity (27) , we examined its effects on HCV IRES-dependent translation. The effects of hnRNP D isoforms were monitored by cotransfection of 293T cells with effector plasmids expressing these proteins (Fig. 1A, panel ii) and a reporter plasmid producing dicistronic mRNA consisting of Renilla luciferase (RLuc), which is translated in a cap-dependent manner, followed by firefly luciferase (FLuc) under the translational control of HCV IRES (nt 18 to 402) (Fig. 1A, panel i, top) . Among the hnRNP D isoforms, p37 and p45 enhanced HCV IRES-dependent translation, as measured from the relative ratio of firefly luciferase to Renilla luciferase activity (Fig. 1B, compare lanes 2 and 5 with lane 1) . The p40 and p42 isoforms had no significant effect on the translation of HCV mRNA in 293T cells (Fig. 1B, panel i , compare lanes 3 and 4 with lane 2), despite similar expression levels of the isoforms on a Western blot (Fig. 1B, panel 1 , ␣-Flag). The p45 isoform showed the strongest translational enhancing activity in Huh7 cells (hepatocellular carcinoma cells), the same as in 293T cells. Interestingly, p42 but not p37 enhanced translation through the HCV IRES in Huh7 cells ( To exclude the possibility that the increase in firefly luciferase activity by p45 protein is due to monocistronic reporter mRNA, which may be generated by cryptic promoter activity, aberrant splicing, or cleavage of dicistronic mRNA by a putative endonuclease, we monitored the integrity of the dicistronic reporter mRNA containing the HCV IRES element by Northern blot analysis with a 32 P-labeled probe corresponding to the firefly luciferase gene (Fig. 1B, panel ii, and C, panel ii). Overexpression of p45 did not affect the integrity of reporter mRNA, and putative RNA of monocistronic mRNA size was not detected (Fig. 1B, panel ii, and C, panel ii). Together, these results indicate that some hnRNP D isoforms enhance HCV IRES-dependent translation in vivo, and the p45 isoform displays the strongest ITAF activity.
We investigated the effects of p45 on several IRES elements through cotransfection of dual reporter plasmids containing HCV, EMCV, and c-myc IRES (Fig. 1A , panel i, and D). Overexpression of p45 enhanced the IRES activity of HCV mRNA, as expected, but did not affect EMCV or c-myc IRESdependent translation in 293T cells (Fig. 1D , upper panel), despite similar levels of the effector protein (p45) (Fig. 1D , lower panel).
We monitored the effects of cotransfection of plasmids expressing NSAP1 and hnRNP D, since hnRNP D interacts with NSAP1. The overproduction of NSAP1 and hnRNP D together showed an additive effect rather than synergistic effect, which might be observed if they functioned in a cooperative manner (data not shown). This suggests that NSAP1 and hnRNP D function independently. Direct interactions of hnRNP D with HCV IRES were confirmed using UV cross-linking and immunoprecipitation. Cytoplasmic extracts of 293T cells transfected with a plasmid expressing the Flag-tagged p45 isoform of hnRNP D or a negative control vector were immunoprecipitated using an anti-Flag antibody after UV cross-linking reactions with 32 Plabeled HCV RNA (nt 18 to 402) and RNase digestion (Fig. 2B,  panel ii) . The p45 protein was clearly detected by UV crosslinking and immunoprecipitation of cell extracts transfected with p45-expressing cells (Fig. 2B, panel ii, lane 4 , and panel iii, lane 3). No band was detected with the extracts of cells transfected with the control vector (Fig. 2B, panel ii, lane 3) or when antihemagglutinin (anti-HA) antibody was used in the immunoprecipitation (Fig. 2B, panel iii, lane 2) . These data strongly suggest that p45 directly interacts with HCV IRES in the cell.
The hnRNP D and HCV IRES interactions were further confirmed using purified p45 protein and radiolabeled RNA corresponding to different portions of the HCV IRES ( Fig.  2A) . Purified hnRNP D protein bound efficiently to RNA containing nt 18 to 129 (Fig. 2B, panel iv, lanes 2, 5, and 6 ) and weakly to those lacking nt 18 to 129 (Fig. 2B, panel iv, lanes 3  and 4) . These data are consistent with the results of protein (Fig. 1A, panel ii) , because p45 showed the strongest ITAF activity (Fig. 1B) . Cell lines expressing shRNA against hnRNP D and negative controls were generated by transfecting HeLa cells with a plasmid expressing hnRNP D-specific shRNA or empty vector and then collecting hygromycin-resistant cells. Cells expressing shRNA against exon 7 of hnRNP D displayed a markedly reduced level of p45 and reduced level of p40/p42 isoforms of hnRNP D, which was most likely due to knockdown of p42, but retained p37 isoform (Fig. 3B, hnRNP D) . On the other hand, the levels of actin and other ITAFs that affect HCV IRES-dependent translation, such as NSAP1, PTB, and La, remained unchanged (Fig. 3B, NSAP1 , PTB, La, and actin), indicating the specificity of this shRNA. The effects of hnRNP D knockdown on HCV IRES-dependent translation were monitored via transfection of dicistronic reporter mRNAs containing HCV IRES or EMCV IRES in the intercistronic regions (Fig. 3A) into control and hnRNP-D knockdown cells. The RNA transfection method was used to eliminate the possibility of aberrant mRNA production through a putative cryptic promoter or cryptic splicing accepter in HCV IRES that might be activated when dicistronic mRNAs are generated by DNA transfection. HCV IRES-dependent translation was reduced upon transfection of dicistronic RNA into hnRNP D knockdown cells compared with control cells (Fig. 3C, lanes 1 and 2) . Notably, about 60% of HCV IRES activity remained, even after knockdown of the p42/p45 isoforms of hnRNP D. Residual translation activity through HCV IRES is possibly attributed, at least in part, to the other isoforms of hnRNP D (p37/p40), because p37 augments HCV IRES-dependent translation (Fig. 1B) and siRNA that suppressed all isoforms of hnRNP D induced much stronger inhibition of HCV IRES activity (see below). On the other hand, translation of EMCV IRES was not affected by knockdown of hnRNP D (Fig. 3C, lanes 3 and 4) . These results, along with p45 expression data (Fig. 1B) , strongly suggest that the p45 isoform of hnRNP D protein augments HCV IRESdependent translation.
Sequestration of hnRNP D with an oligodeoxynucleotide impedes HCV IRES-dependent translation in vitro.
Previously, we developed a useful method to identify the cellular proteins augmenting IRES activities (9) . The underlying principle of this method is that several RNA-binding proteins bind to specific DNA sequences. Thus, addition of an oligodeoxynucleotide that specifically interacts with an RNA-binding protein, such as ITAF, inactivates protein function through sequestration from its own target RNA (9) . hnRNP D interacts strongly with the G-rich strand of telomeric DNA repeats (TTAGGG) 4 (12) . A G-to-C substitution of the fifth nucleotide, (TTAGCG) 4 , abolishes the hnRNP D-binding capacity of telomeric DNA repeats. To determine the function of hnRNP D in HCV IRES-dependent translation, we monitored the effects of (TTAGGG) 4 and (TTAGCG) 4 on HCV IRES-dependent translation using an in vitro translation system. In vitro translation reactions of monocistronic reporter mRNA containing HCV IRES or EMCV IRES, followed by firefly luciferase (Fig. 4A) , were performed in HeLa S10 extracts in the presence of (TTAGGG) 4 or (TTAGCG) 4 (hereafter referred to as G5 and C5, respectively). Addition of G5 DNA oligomers, which bind hnRNP D with high affinity, inhibited HCV IRES-dependent translation in a dose-dependent manner (Fig. 4B, lanes 2 and 3) . On the other hand, C5 DNA oligomers that bind weakly to hnRNP D inhibited HCV IRESdependent translation only slightly, even at high concentrations (Fig. 4B, lanes 4 and 5) . Neither G5 nor C5 oligomers inhibited EMCV IRES-dependent translation, indicating that the inhibitory effect of the G5 oligomer on HCV IRES-dependent translation is not attributed to nonspecific inactivation of the translation system (Fig. 4B, lanes 6 to 10) . These data also G5 (lanes 2, 3, 7 , and 8) and C5 (lanes 4, 5, 9, and 10) oligomers or in the absence of oligonucleotides (lanes 1 and 6) . The final concentrations of oligomers were 2 M (lanes 2, 4, 7, and 9) or 4 M (lanes 3, 5, 8, and 10) . The firefly luciferase activity in extracts without oligomers was set to 1. Experiments were performed at least three times for each experimental set, and standard deviations are presented as error bars. NT, not treated. tigating the effects of siRNA against hnRNP D on HCV IRES activity. In this case, we used siRNA targeting all different isoforms of hnRNP D (Fig. 1A, panel ii) . Compared with cells transfected with control siRNA, those transfected with siRNA against hnRNP D displayed markedly reduced levels of all isoforms of hnRNP D (Fig. 5B, panel i, hnRNP D) . Interestingly, the level of NS5B protein under the control of the EMCV IRES was increased about twofold in cells depleted of hnRNP D (Fig. 5B, panel i, NS5B , and panel ii). This effect is possibly attributable to the twofold increase in the level of HCV RNA in hnRNP D-depleted cells, as measured by realtime PCR in cells transfected with siRNA against hnRNP D (Fig. 5B, panel iii; also see below) . Depletion of hnRNP D did not affect EMCV IRES-dependent translation (Fig. 3C and  4B ). It is plausible that hnRNP D blocks replication of HCV to avoid the collision between translational and replication machineries. An analogous situation is reported for the interplay between translation and replication of polioviral RNA (4, 15) , where PCBP and/or PTB have key roles in the switch from translation to replication (see Discussion, below). Further investigation is required to clarify the molecular basis of the increase in the HCV RNA level in hnRNP D-depleted cells. Importantly, the level of firefly luciferase under the control of the HCV IRES was reduced by about 60% in cells transfected with siRNA against hnRNP D (Fig. 5B, panel iv) . The actual effect of hnRNP D knockdown on HCV IRES function is even more dramatic (about 80%), considering the increased HCV RNA level (Fig. 5B, panel v; relative luciferase activities in panel iv were normalized with RNA levels in panel iii).
The necessity of hnRNP D in proliferation of HCV, which requires both translation and replication of RNA, was monitored using a monocistronic HCV replicon, Huh 5-15, containing the hygromycin resistance gene and HCV NS3 to NS5B in a single open reading frame (Fig. 5A, lower panel) (13) . This artificial polyprotein is translated through the HCV IRES and processed by ubiquitinase and the viral proteinase NS3, resulting in functional proteins. Under these conditions, expression of NS5B controlled by HCV IRES was reduced by 80% upon suppression of hnRNP D with siRNA (Fig. 5C, panel i, NS5B , and panel ii). On the other hand, the HCV RNA level was reduced by 20% (Fig. 5C, panel iii) Fig. 5B and C) . The importance of hnRNP D in HCV mRNA translation was further analyzed by monitoring the ribosomal profiles of HCV mRNA with or without treatment with siRNAs against hnRNP D (Fig. 6) . The overall profiles of ribosomes in sucrose gradient analyses were not altered by treatment with siRNA against hnRNP D. This is reflected in the levels of a control GAPDH mRNA (Fig. 6C) . On the other hand, a shift of HCV mRNA from heavy polysomes (fractions 7 and 8) to light polysomes (fractions 3 to 6) was observed in cells treated with siRNA against hnRNP D (Fig. 6D, lanes 3 to 8) . The effects of hnRNP D on HCV IRES activity in replicons collectively suggest an important role of the protein in translation of HCV mRNA.
Effect of hnRNP D on translation of HCV mRNA during infection. Finally, we monitored the effects of hnRNP D suppression on viral RNA proliferation, using an infectious HCV clone containing Renilla luciferase fused with NS5A viral protein (24) . The luciferase activity reflects the level of viral protein translated in HCV-infected cells. Upon treatment with specific siRNA, the hnRNP D protein level was markedly reduced, with no effects on the amount of the negative control protein, actin (Fig. 7C) . Expression of viral proteins in hnRNP D siRNA-treated cells was reduced to about 70%, as measured by luciferase activity (Fig. 7B, panel i) or Western blotting of NS5A-Rluc fusion protein and core protein (Fig. 7C, NS5A Rluc and core). Similar to the replicon system, the viral RNA level in infected cells was marginally reduced in hnRNP Ddepleted cells (Fig. 7B, panel ii) . These data strongly suggest that hnRNP D participates in HCV proliferation by augmenting IRES activity.
DISCUSSION
Translational initiation through the HCV IRES is unique for eukaryotic mRNA, because only a few canonical translation factors (eIF2, eIF3, eIF5, and eIF5B, but not eIF4E, eIF4A, or eIF4G) are used for activity (40) (41) (42) . However, a number of noncanonical translation factors (PTB, La, and NSAP1) augment HCV IRES-dependent translation. Here, we report that hnRNP D, an RNA-binding protein, augments HCV IRES activity through binding to the SL II region of the IRES element. Several lines of evidence confirm that hnRNP D is a positive regulator of HCV IRES-dependent translation. First, overexpression of hnRNP D enhanced HCV IRES-dependent translation (Fig. 1B and C) . The p45 isoform of hnRNP D displayed the strongest IRES-enhancing activity (Fig. 1B and  C) . Additionally, hnRNP D specifically activated HCV IRESdependent translation among the IRES elements examined ( Fig. 1D) . Second, hnRNP D interacted with SL II of the HCV IRES element (Fig. 2) . Third, knockdown of hnRNP D with siRNAs inhibited HCV IRES activity monitored using a dicistronic reporter (Fig. 3) , HCV replicons (Fig. 5) , and an infectious HCV clone (Fig. 7) . Fourth, the G5 oligomer that binds to hnRNP D specifically inhibits HCV IRES-dependent translation in vitro (Fig. 4) . Finally, a significant amount of HCV replicon RNA was shifted from heavy to light polysomal fractions in hnRNP D knockdown cells (Fig. 6) .
We speculate on the mechanism by which hnRNP D augments IRES-dependent translation, based on the molecular properties of hnRNP D. SL II, the binding site of hnRNP D (Fig. 2B , panels i and iv), is related with IRES-dependent translation. Mutations in this region inhibit transition from the 48S to 80S complex (37) . This effect may be related with the SL II function mediating eIF2 release by promoting eIF5-induced GTP hydrolysis, which facilitates 80S complex formation (34, 39) . Therefore, it is possible that hnRNP D facilitates 60S joining by inducing the critical bent structure in SL II (34) through its intrinsic property of rearranging nucleic acid chains (12) . Alternatively, hnRNP D may enhance HCV IRES-dependent translation through interactions with another protein(s) that promote translational initiation. In this respect, it is worth noting that hnRNP D interacts with NSAP1 (16), enhancing HCV IRES-dependent translation (27) . However, synergistic activation of the HCV IRES was not observed when these two proteins were overexpressed together in the cells (data not shown), indicating that these proteins enhance HCV IRES activity independently. Intriguingly, knockdown of ITAF hnRNP D facilitates the replication of HCV RNA. This finding suggests that hnRNP D is involved in the functional switch from the translational mode of incoming HCV RNA to the replication mode. After the synthesis of viral proteins, including RNA-dependent RNA polymerase (NS5B), genomic viral RNA should serve as a template for the synthesis of negative-strand RNA. The switch from translation to replication should occur properly, because continuous translation of viral mRNA blocks the replication of viral RNA (15) . RNA-binding proteins play key roles in the functional switch from translation to replication of poliovirus, which displays a similar life cycle to HCV. Specifically, poliovirus is a positive-sense RNA virus, and its translation is directed by an IRES element at the 5Ј NTR of viral RNA, such as HCV (38) . Poly(rC)-binding protein (PCBP) interactions with domain IV in the poliovirus IRES element enhance IRES activity. Functional switching from translation to replication of viral RNA possibly occurs by changes in PCBP2-binding sites from domain IV to the 5Ј-terminal cloverleaf of the polioviral 5Ј NTR (14, 15) . More recent results suggest that proteolytic cleavage of PTB (which binds to the IRES element of polioviral RNA and enhances IRES function) by the virus-encoded proteinase 3C pro induces functional switching from translation to replication (4) . An analogous functional switch may occur during infection of HCV. One possible hypothesis is that hnRNP A1, which displays similar binding specificity to hnRNP D (17, 20) and is required for HCV RNA replication (25) , competes with hnRNP D for the same binding site in SL II. In this respect, it is interesting that hnRNP A1 in the nucleus in noninfected cells relocalizes to the cytoplasm in HCV-infected cells, where translation and replication occur (25) . Therefore, the shift from hnRNP D-bound RNA to hnRNP A1 may result in a switch from translation to replication of RNA.
Further investigation of the functions of hnRNP D should improve our understanding of the mechanisms of IRES-dependent translation and replication. Moreover, this improved knowledge may lead to the development of novel therapeutic approaches for the treatment of life-threatening HCV infections.
